Press releases

Start / Newsroom / Press releases

2017-08-25 08:46 Full drug dose achieved in prostate trial Regulatory MAR

2017-07-05 08:45 EU Grant awarded through Vinnova Regulatory MAR

2017-06-26 09:47 An additional patient has been treated in Toronto, Canada Regulatory MAR

2017-06-01 10:36 Patent for dose control approved in Canada Regulatory MAR

2017-05-23 15:15 Communiqué from the Annual General Meeting 2017 Regulatory

2017-05-18 11:58 SpectraCure initiates a joint project with German company MedCom GmbH Regulatory MAR

2017-04-24 09:58 Patient treatments started in clinical Phase 1 study Regulatory

2017-04-21 08:17 Notice of annual general Meeting of SpectraCure AB (publ) Regulatory

2017-01-24 13:30 The first day of trading with warrants of series TO2 is estimated at 27 January 2017 Regulatory

2017-01-18 17:03 SpectraCure decides on Set-off Issue Regulatory